Category Archives: Neuroscience

‘Out of control:’ students share their struggles with eating disorders – University Press

Editors note: The Counseling and Psychological Services hotline is 561-297-3540.

Breanna Jomsky didnt get her period for four years.

From late 2011 to 2015, she lived with anorexia, an eating disorder characterized by difficulties maintaining an appropriate body weight for height, age, and stature and, in many individuals, distorted body image, according to the National Eating Disorder Association (NEDA). Because she was exercising too much and eating too little, her body wasnt able to release an important hormone thats necessary for periods.

She also bruised easily, slept awfully and cried frequently at the thought of eating food.

Now, the cellular neuroscience major says shes as fully recovered as possible. But there are college students who are still struggling with eating disorders. According to the NEDAs most recent data, roughly 5 percent of students enter college with an eating disorder.

This week, NEDA celebrated Eating Disorder Awareness Week, where they encouraged people to reflect on the positive steps youve taken including those stemming from setbacks or challenges toward accepting yourself and others, their website says.

While Jomsky dealt with anorexia, another FAU student, environmental engineering major Samuel Gerstein is currently recovering from binge eating disorder, which is characterized by recurrent episodes of eating large quantities of food often very quickly and to the point of discomfort and a feeling out-of-control while binging, according to NEDA.

Here are Jomskys and Gersteins stories with each of their eating disorders:

Around August 2011, when Breanna Jomsky was 13 years old, her parents sent her to an endocrinologist because of her menstrual pains. Jomsky said the rude doctor had zero bedside manner, and told her she should lose 15 to 20 pounds. After that, she lost 30 pounds in just three months.

I slowly started eating healthier, Jomsky said, but that just went out of control.

Over the next few years, she ended up visiting five different psychologists. She also saw a nutritionist but was reluctant to.

Jomsky started out lying to her nutritionist about what and how much she was eating and became obsessed with counting calories.

Id be in class and have my calculator out and it would be Spanish and Id be trying to plan things out for the day, she said. That was something that took a lot of brain space and energy.

There are apps that count calories for you now, like MyFitnessPal and Lifesum. But a BBC investigation last year reported that those apps can exacerbate such behaviors and make recovery harder.

Jomsky had eventually lost so much weight that when she would sit in the passenger seat of her moms Honda, the dashboard would notify her that the airbag in her seat was off. She said she didnt weigh enough to activate it.

During that time, she would go to the gym and just to cardio. She avoided parties because of the food and cried at the thought of eating a bowl of pasta.

After getting comfortable with her nutritionist, Jomsky began to gain back weight and she eventually started getting her period again.

Having an eating disorder is like: you want to get better but you dont, Jomsky said. Theres a lot of cognitive dissonance, or inconsistent thoughts about your own attitude or behavior.

Now, Jomsky doesnt just eat the crusts of her turkey sandwiches as a snack anymore or bruise just from sleeping. She lifts at the gym, paints in her Jupiter dorm and sings covers of rock songs.

She thought that once she gained a certain amount of weight, she would just lose it all again.

That didnt happen, luckily, she said. I worked too hard to get to where I was and I was starting to feel better about myself and my body and I just didnt want to go back there.

Samuel Gersteins eating disorder started to develop when he was around 13 years old, he said. Thats when he started the ketogenic diet, which is very restrictive in carbs and high in fat.

Even though it was very extreme, he said, he lost 60 pounds in a year and maintained it for longer than that. But he eventually started to stray away from it and started binging on weekends.

I would eat copious amounts of carbs and sugary food because I was depriving myself of it, he said. As school started to get harder, I noticed I would binge and I would literally just shove food down my throat. And it kind of got out of hand.

Now 16 years old, the FAU High environmental engineering major said hes recently started to recover by going to therapy.

He stopped following the ketogenic diet around last September, since Hurricane Dorian hit Florida and the same high-fat foods werent going to be available to him. But once he stopped, he said he felt so much better.

Why was I eating that way? he asked himself after coming off the diet. I shouldnt be having this infinite sense of hunger.

One of the biggest misconceptions he thinks people have about eating disorders is that you have to look a certain way specifically, he said, its not just people who are skinny that have eating disorders.

According to NEDA, binge eating disorder is three times more common than anorexia and bulimia combined.

People like myself, that do engage in disordered eating, arent aware that you dont need to be 2 percent body fat to have an eating disorder, he said. You can be skinny and you can be healthy; you can be chubby and you can have anorexia; or you can be skinny and have binge eating disorder.

Gerstein also advocated for people who may have eating disorders but dont yet know it because they cant afford the means to get help, like low-income families. He argued that structural change needs to be made to allow more people access to nutritious food rather than frozen and canned foods.

I think that we have a very fatphobic culture inside of our health institutions, as well as inside of our inside of our social system, he said. And its a very degrading system of oppression that we see.

Kristen Grau is the editor-in-chief of the University Press. For information regarding this or other stories, email [emailprotected] or tweet her at @_kristengrau.

Continued here:
'Out of control:' students share their struggles with eating disorders - University Press

New genes preventing healthy aging in China – Free Press Journal

Chinese researchers found that two new genes can prevent healthy aging, which provides a theoretical basis for delaying brain aging, according to a report by Science and Technology Daily.

The research published in Nature was jointly carried out by two research teams from the Institute of Neuroscience, Chinese Academy of Sciences (CAS) and the Institut Pasteur of Shanghai, CAS.

Previous studies found that longevity genes do not necessarily delay the behavioral deterioration of animals in aging, which means increasing longevity is rarely accompanied by an extended healthspan.

Through screening of genes that regulate behavioral deterioration in aging Caenorhabditis elegans and the examination of human databases, researchers found that the expression of two genes, BAZ2B and EHMT1, increases with age and correlates positively with the progression of Alzheimer's disease, said the research paper.

The research further showed that reducing the function of BAZ2B can improve cognitive function and behavioral ability of aging C. elegans or mice.

Considering the large species differences between human beings and animals, there is still great uncertainty as to whether the study can be applied to human beings, the researchers said.

Read more:
New genes preventing healthy aging in China - Free Press Journal

Roche To Top $66 Billion In Sales By 2020, Led By Neuroscience – Forbes

Sign with logo on facade at office of pharmaceutical company Roche in Pleasanton, California, July ... [+] 2, 2019. (Photo by Smith Collection/Gado/Getty Images)

Roche Holdings (OTCMTS: RHHBY) revenue grew at a CAGR of 5.3% from $52.5 billion in 2015 to $64.4 billion in 2019, and it is estimated to top $66 billion in 2020, led by its Neuroscience drugs. The companys oncology drugs will account for 45% of the companys total sales in 2020, but Neuroscience drugs are key to the near term revenue growth, in our view. Oncology drugs are expected to be the single-biggest revenue driver with $30.1 billion in revenues (45% of Total Revenues), which is 5.7x the size of its Neuroscience drugs revenue in 2020. Neuroscience drugs revenues, which includes Ocrevus and Modopar among other drugs, will be the fastest-growing segment adding $3.7 billion over 2017-2020 (32% of $11.6 billion in incremental revenues). Oncology drugs revenues, which includes Herceptin, Perjeta, Tecentriq, and Avastin among other drugs, will add about $3.4 billion over 2017-2020 (29% of the $11.6 billion in incremental revenue). Look at our interactive dashboard analysis on Roches Revenues for more details, parts of which are highlighted below.

Roches Revenue Has Been On A Rise Over The Last Few Years

Comparing Roches Sales Growth To Its Peers

oche Has One of The Largest Oncology Drugs Portfolio, But It Is Expected To See A Decline Going Forward.

Ocrevus Has Been The Best Drug Launch Ever For Roche, Boosting Its Neuroscience Drugs Portfolio

Other Therapeutic Drugs Could Also See Growth In The Near Term

Among Other Segments, In-Vitro Diagnostics Could Continue To Grow At A Steady Pace, While Immunology, Ophthalmology, And Virology Drugs Could See A Decline

See allTrefis Price EstimatesandDownloadTrefis Datahere

Whats behind Trefis? See How Its Powering New Collaboration and What-Ifs ForCFOs and Finance Teams |Product, R&D, and Marketing Teams

Read the original:
Roche To Top $66 Billion In Sales By 2020, Led By Neuroscience - Forbes

Wave Neuroscience Acquires Assets of NeoSync – Yahoo Finance

NEWPORT BEACH, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Wave Neuroscience, Inc., a global leader in developing personalized, noninvasive technology aimed at addressing neurological disorders and enhancing cognitive brain function through Transcranial Magnetic Stimulation (TMS), announced today that it has acquired the assets of NeoSync, Inc. NeoSync is a pioneer in personalized, low-energy brain stimulation for the treatment of Major Depressive Disorder and other diseases of the Central Nervous System (CNS).

Among the assets acquired are 19 issued and four pending patents which will be added to Waves existing portfolio, strengthening Waves position in EEG and EEG/EKG guided TMS. In addition, Wave has acquired the Neuro-EEG Synchronization Therapy (NEST) system developed and tested by NeoSync. The NEST device is a technologically advanced helmet design that imparts stimulation at precise frequencies to the patients brain and has shown promising results in clinical trials. Wave will work towards proving the safety and efficacy of the NEST platform, incorporating its algorithms and moving to eventual FDA clearance for this novel, portable, in-home technology.

We are very excited to add NeoSyncs complementary IP and products to our rapidly growing suite of technologies, said Fred Walke, CEO of Wave. This acquisition further exemplifies our commitment to creating and optimizing what others are now realizing is possible: targeted and personalized neuromodulation that honors an individuals unique physiology more closely than the one-size-fits-all approach commonly used today. We find especially compelling the fact that the NEST is designed for eventual home-use. Once commercially available, the NEST will provide wide accessibility to this groundbreaking treatment, improving the quality of life for many.

Kate Rumrill, NeoSyncs president and CEO said, We are pleased Wave is taking over the stewardship of the NeoSync technology assets and heartened by its commitment to maximize the tremendous potential of the NEST system. We look forward to seeing the technology reaching its full capabilities, providing broader access to patients in need.

About Wave Neuroscience:Wave Neuroscience was established to empower and optimize brain function. The companys patented MeRT process improves non-invasive neuromodulation technology by precisely adjusting neural networks to address a wide range of neurological disorders, as well as enhance cognitive performance, using non-pharmacological methods. The companys precise, personalized therapy analyzes brainwave activity using machine-learning that helps guide decisions on treatment stimulation parameters. MeRT treatments are administered to patients by skilled physicians using FDA-cleared equipment at 14 locations worldwide, including 12 in the United States. On the web: http://waveneuro.com/.

Contact: Spencer J. Vigoren(949) 541-8580spencer@waveneuro.com

Read the rest here:
Wave Neuroscience Acquires Assets of NeoSync - Yahoo Finance

Science in the service of humanity: Princeton joins Rutgers, NJIT to advance health-related innovations – Princeton University

Princeton faculty and student researchers make many discoveries that have the potential to address cancer, infectious disease, autism and other development disorders, and other medical, behavioral and health challenges.

Now, a collaboration with Rutgers University and the New Jersey Institute of Technology is making it easier and faster for Princeton's medical and health-related research to reach patients and the community.

The collaboration, known as the New Jersey Alliance for Clinical and Translational Science (NJ ACTS), began in 2019 and is funded by a $29 million grant from the National Institutes of Health to speed the translation of research into innovations that can lead to improvements in patient and public health.

With NIH support, NJ ACTS is organized into 14 core areas that provide research grants, training, mentoring, informatics, collaborations with community groups and industry, programs that address underserved populations, and improved access to clinical trials.

Julie-Anne Rodier, a postdoctoral research associate in the Princeton Neuroscience Institute (right) is studying the potential effects of gene-related factors on the risk of opioid addiction in the laboratory of Catherine Jensen Pea, assistant professor of neuroscience (left).

Photo by

Denise Applewhite, Office of Communications

"This new relationship builds a bridge between Princeton researchers and the patient-centered activities of Rutgers University, its medical school and alliances with hospitals," said Dean for Research Pablo Debenedetti, the Class of 1950 Professor in Engineering and Applied Science and a professor of chemical and biological engineering, who serves on the Board of Directors of NJ ACTS. "Working together in collaboration, all three institutions are stronger and more capable of addressing today's health and medical challenges than each institution would be on its own."

Princeton brings to the partnership strengths in research on cancer, hepatitis and other diseases; understanding how social disparities affect health; new ways to apply artificial intelligence and machine learning to health care challenges; new medical technologies; community interventions and other approaches.

Through the alliance with Rutgers Biomedical and Health Sciences, the lead academic partner in the collaboration, Princeton researchers are more easily able to interact with clinical partners, including medical, nursing, dental and public health schools, hospitals, community health centers, industry, and policymakers. They can also more readily gain access to resources needed to advance their translational research, such as tissue samples, blood cells, core facilities and patients for studies.

"NJ ACTS allows us to collaborate with investigators at Rutgers who have a broader or deeper understanding of research related to patients, what problems need to be studied, and the best way to study them," said Daniel Notterman, who heads Princeton's role in the alliance and is a senior research scholar and a lecturer with the rank of professor in molecular biology, and a practicing physician. "NJ ACTS serves as a way to connect our faculty and student investigators to the questions they want to answer."

Researchers in the lab of Pea, an NJ ACTS pilot-program awardee, track cell cycles in mice.

Photo by

Denise Applewhite, Office of Communications

One of the significant benefits of the collaboration is the potential to bridge gaps between research communities, said Sam Wang, a professor of neuroscience and leader of the NJ ACTS pilot grants program at Princeton. "Modern biological research is increasingly complex, and opportunities are much greater if one can call upon a diversity of experimental and conceptual tools."

"The program can help overcome the barriers to translation of research that Princeton faculty and students sometimes face," said Noreen Goldman, the Hughes-Rogers Professor of Demography and Public Affairs at the Woodrow Wilson School, and the head of two Princeton NJ ACTS sections, biostatistics and workforce development. "The grant has already fostered interactions and collaborations between Princeton and Rutgers in unanticipated ways."

The network of medical professionals and clinical experts benefits both research and teaching, said Daniel Cohen, an assistant professor of mechanical and aerospace engineering who, as a member of the NJ ACTS Academy of Mentors, provides training to Princeton graduate students and postdoctoral researchers. "I teach a class on medical devices and biomaterials," Cohen said, "and it is very helpful for students to hear firsthand from clinicians what they like and dislike about the medical devices they use on an everyday basis."

One research area that Princeton will focus on is the use of artificial intelligence and machine learning to improve the understanding of the brain, said Jonathan Cohen, the Robert Bendheim and Lynn Bendheim Thoman Professor in Neuroscience, professor of psychology and neuroscience, and co-director of the Princeton Neuroscience Institute, and one of the Princeton faculty members who helped organize the collaboration. "With NJ ACTS collaborators, we'll be able to examine large data sets to look for patterns of brain and behavioral activity, and test their relevance to psychiatric disorders directly in clinical studies."

Through NJ ACTS, Princeton awards pilot research grants as well as training grants for graduate students and postdoctoral researchers at Princeton. To date, four faculty members have received pilot grants, awarded on a competitive basis, across a range of biomedical and health-related topics:

Two translational science training fellowships have been awarded on a competitive basis to two early-career researchers:

Seven Princeton faculty members are engaged in core leadership roles providing infrastructure, tools, services and expertise to the NJ ACTS community of clinical and translational researchers, trainees and staff.

Princeton has a long history of collaboration with Rutgers, including the joint M.D./Ph.D. program in which students can complete the laboratory portion of the degree at Princeton and earn their medical degree at Rutgers Robert Wood Johnson Medical School. NJ ACTS is one of the 58 NIH-funded clinical and translational hubs nationwide.

"This program is another step in reducing the barriers between institutions so that patients can access care sooner," Notterman said. "This is another way for Princeton faculty and Princeton students to work in the nation's service."

The collaboration is supported by the National Institutes of Health Clinical and Translational Science Awards (CTSA) Program grants UL1TR003017, KL2TR003018 (career development) and TL1TR003019 (training).

Learn more about funding opportunities, training and resources available through NJ ACTS. To apply for a grant through the NJ ACTS pilot program, contact Bianca Freda, Class of 1998, or access the application on the NJ ACTS website.

More:
Science in the service of humanity: Princeton joins Rutgers, NJIT to advance health-related innovations - Princeton University

New California Bill Aiming to Eliminate Racial and Other Biases in Hiring – Lasentinel

(Courtesy photo)

Imagine applying for a job online.

But instead of a hiring manager or some pre-screening software reviewing your application and pushing it along or eliminating it based on personal biases or other random criteria a company sets up, a smart computer program that is agnostic does the filtering, determining whether you are a good fit for the job or not.

Relying only on your qualifications and experience, the program does not consider factors like your name, your zip code, social connections or where you went to school in the screening process.

Sounds too futuristic? Well, the future may be right now at least in California.

On Friday, lawmakers in California introduced SB 1241 or the Talent Equity for Competitive Hiring (TECH) Act. The bill sets a new legal high bar against discrimination in hiring by writing clear guidelines for employers to follow that allow them to modernize their recruiting processes using technological tools that reduce bias, leading to a more diverse workforce.

Sen. Lena Gonzalez (D-Long Beach) introduced the legislation in the Senate. Assemblymember Reggie Jones-Sawyer (D-South Los Angeles), Sen. Steven Bradford (D-Gardena), and Assemblymember Mike A. Gipson (D-Carson) are co-authors.

California has a growing opportunity gap that leaves many families and communities in our state behind, said Gonzalez after she introduced the bill in Long Beach along with leaders from community based organizations and social justice groups. Hiring discrimination plays a significant role in our current inequality. The TECH Act will help ensure access to jobs that offer competitive wages and upward mobility for all our residents.

The TECH Act states assessment technologies will be considered in compliance with anti-discrimination rules if: 1) they are pre-tested for bias before being deployed and found not likely to have an adverse impact on the basis of gender, race or ethnicity; 2) outcomes are reviewed annually and show no adverse impact or an improvement of hiring among underrepresented groups; and 3) their use is discontinued if a post-deployment review indicates adverse impact.

Last September, the California Assembly voted unanimously to pass ACR 125, also known as the Fair Hiring Resolution. ACR 125 was a call to action for the states lawmakers to pass legislation that tackles implicit racial and social biases in corporate hiring by creating clear rules of the road for how employers can use these smart technologies.

Five months later, their motion has become a reality.

Innovative technologies for hiring and promotion, including artificial intelligence and algorithm-based technologies, have the potential to reduce bias and discrimination in hiring and promotion based on protected characteristics, such as socioeconomic status or status as a formerly incarcerated person, the resolution read.

At the same time, these technologies can help employers reach larger and more diverse pools of qualified talent and better identify candidates with the right skills and abilities to succeed, it went on to make the case for the merits of the legislation.

Jones-Sawyer and Gonzalez introduced the resolution in August last year. It was co-authored by Assemblymember Sydney Kamlager-Dove (D-Los Angeles), Assemblymember Chris Holden (D-Pasadena), and Assemblymember Evan Low (D-Silicon Valley).

California is one of the most diverse states in the nation. Our diversity is our strength, but corporate executive offices and boardrooms across our state frequently fail to reflect the same diversity, Jones-Sawyer points out.

Just look at San Franciscos Silicon Valley high tech sector as an example, he explained. Women make up just 36.7 percent of the workforce; 3.3 percent of the workforce is Black; and only 6.6 percent is Hispanic. Thats unacceptable.

The TECH Act builds on a series of laws California has passed in recent years to fight discrimination in hiring, such as ban the box legislation prohibiting employers from asking about an applicants criminal history before giving a conditional job offer, according to Jones-Sawyer.

Frida Polli is a co-founder at Pymetrics, a company that makes neuroscience games using artificial intelligence that are designed to eliminate the biases in hiring the resolution intends to prevent.

Before we release the technology, we look at the outcomes and audit it. And we go through the audit, she told California Black Media. We are giving an objective data point or an objective score for employers. It is mitigating the human biases of employers. All of us are biased. The way a lot of these tools work are customized for each role. We have employees working with each of our clients. It is not a one-size-fits-all solution.

According to Pymetrics, the companys AI tools is based on decades of research and technology developed by the global neuroscience community.

They are widely considered the gold-standard of neuroscience research, and measure established building blocks of cognitive and emotional functioning, akin to the DNA of cognition and personality, the company website reads.

Jones-Sawyer says he realizes that there will be kinks to work out in what the law legislates but he hope this technology can be used everywhere, starting with large companies in the state.

At the beginning we will have to prove the technology, Jones-Sawyer concedes. We will have to offer it and hope their some companies are willing to take a chance. If we mandate it, it could sabotage us before we get out of the gate. We will have to be sure there is not government overreach with this.

California has some of the strongest legal employee protections in the country. But even with the existing state and federal laws that prohibit discrimination in hiring and firing, Black and Latino workers still face significant discrimination in hiring, according to a 2017 Harvard Business Review report.

The study found that employers called back White applicants 36 percent more times than they did Black applicants with identical resumes. For Latinx applicants, that differential was 24 percent. It also found that the standardized tests some employers use to screen potential employees have been proven to identify qualified candidates, but leads to biased outcomes.

In another study conducted in 2012, researchers switched the names on women resumes to male names. The swap improved ratings from professors who were reviewing the resumes to select candidates for STEM research positions.

This is an amazing, amazing initiative, says Rhonda Gregory, co-founder of the National Diversity Coalition, a non-profit social justice organization that supports the legislation. I think it needs to be sooner than later. Im all for it. For me, this is so compelling. You look at a persons name or gender or area where they are from and people tend to say oh no I dont want to deal with that.

See more here:
New California Bill Aiming to Eliminate Racial and Other Biases in Hiring - Lasentinel

World Community Film Series presents Tuning the Brain with Music – Comox Valley Record

A still from the film Tuning the Brain with Music. Photo supplied.

Tuning the Brain with Music, a new life-affirming documentary, highlights the creative encounter between music and neuroscience by featuring the moving stories of people whose mental health and lives have been saved by music.

Award-winning director Isabelle Raynauld spent five years investigating the influence music has on the brain. The film screens Tuesday, March 3 at 7 p.m. in the Stan Hagen Theatre, North Island College.

The healing powers of music on the brain are finally being recognized. This film allows us to discover cutting-edge research in musical neuroscience through the stories of people for whom music has succeeded where other therapies have not.

The film alternates between neuroscientific research, music therapists in session and the touching personal stories.

The human stories at the heart of the film are many and varied: premature babies in intensive care units appeased by music therapy sessions; Canadian veterans suffering from post-traumatic stress who have been saved from suicide by music; autistic girls who have formed a band; survivors of cancer and stroke for whom music has been an integral part of their healing protocol; and at-risk youth for whom music is their lifeline.

Raynauld also introduces us to some of the worlds leading researchers in neuroscience in order to better understand what is actually happening in the brain.

The other aspect that attracted me to this subject was the obvious but still unexplained powerful healing powers of music on the mental health and overall well-being of people, she said. Their amazing and moving life stories have changed mine forever.

Admission is by donation.

FMI: 250-337-5412

Comox Valleyfilm

Read the original post:
World Community Film Series presents Tuning the Brain with Music - Comox Valley Record

New California Bill Aiming to Eliminate Racial And Other Biases in Hiring – Sacramento Observer

(CBM) Imagine applying for a job online.

But instead of a hiring manager or some pre-screening software reviewing your application and pushing it along or eliminating it based on personal biases or other random criteria a company sets up, a smart computer program that is agnostic does the filtering, determiningwhether you are a good fit for the job or not.

Relying only on your qualifications and experience, the program does not consider factors like your name, your zip code, social connections or where you went to school in the screening process.

Sounds too futuristic? Well, the future may be right now at least in California.

On Friday, lawmakers in California introduced SB 1241 or the Talent Equity for Competitive Hiring (TECH) Act. The bill sets a new legal high bar against discrimination in hiring by writing clear guidelines for employers to follow that allow them to modernize their recruiting processes using technological tools that reduce bias, leading to a more diverse workforce.

Sen. Lena Gonzalez (D-Long Beach) introduced the legislation in the Senate. Assemblymember Reggie Jones-Sawyer (D-South Los Angeles), Sen. Steven Bradford (D-Gardena), and Assemblymember Mike A. Gipson (D-Carson) are co-authors.

California has a growing opportunity gap that leaves many families and communities in our state behind, said Gonzalez after she introduced the bill in Long Beach along with leaders from community based organizations and social justice groups. Hiring discrimination plays a significant role in our current inequality. The TECH Act will help ensure access to jobs that offer competitive wages and upward mobility for all our residents.

The TECH Act states assessment technologies will be considered in compliance with anti-discrimination rules if: 1) they are pre-tested for bias before being deployed and found not likely to have an adverse impact on the basis of gender, race or ethnicity; 2) outcomes are reviewed annually and show no adverse impact or an improvement of hiring among underrepresented groups; and 3) their use is discontinued if a post-deployment review indicates adverse impact.

Last September, the California Assembly voted unanimously to pass ACR 125, also known as the Fair Hiring Resolution. ACR 125 was a call to action for the states lawmakers to pass legislation that tackles implicit racial and social biases in corporate hiring by creating clear rules of the road for how employers can use these smart technologies.

Five months later, their motion has become a reality.

Innovative technologies for hiring and promotion, including artificial intelligence and algorithm-based technologies, have the potential to reduce bias and discrimination in hiring and promotion based on protected characteristics, such as socioeconomic status or status as a formerly incarcerated person, the resolution read.

At the same time, these technologies can help employers reach larger and more diverse pools of qualified talent and better identify candidates with the right skills and abilities to succeed, it went on to make the case for the merits of the legislation.

Jones-Sawyer and Gonzalez introduced the resolution in August last year. It was co-authored by Assemblymember Sydney Kamlager-Dove (D-Los Angeles), Assemblymember Chris Holden (D-Pasadena), and Assemblymember Evan Low (D-Silicon Valley).

California is one of the most diverse states in the nation. Our diversity is our strength, but corporate executive offices and boardrooms across our state frequently fail to reflect the same diversity, Jones-Sawyer points out.

Just look at San Franciscos Silicon Valley high tech sector as an example, he explained. Women make up just 36.7 percent of the workforce; 3.3 percent of the workforce is Black; and only 6.6 percent is Hispanic. Thats unacceptable.

The TECH Act builds on a series of laws California has passed in recent years to fight discrimination in hiring, such as ban the box legislation prohibiting employers from asking about an applicants criminal history before giving a conditional job offer, according to Jones-Sawyer.

Frida Polli is a co-founder at Pymetrics, a company that makes neuroscience games using artificial intelligence that are designed to eliminate the biases in hiring the resolution intends to prevent.

Before we release the technology, we look at the outcomes and audit it. And we go through the audit, she told California Black Media. We are giving an objective data point or an objective score for employers. It is mitigating the human biases of employers. All of us are biased. The way a lot of these tools work are customized for each role. We have employees working with each of our clients. It is not a one-size-fits-all solution.

According to Pymetrics, the companys AI tools is based on decades of research and technology developed by the global neuroscience community.

They are widely considered the gold-standard of neuroscience research, and measure established building blocks of cognitive and emotional functioning, akin to the DNA of cognition and personality, the company website reads.

Jones-Sawyer says he realizes that there will be kinks to work out in what the law legislates but he hope this technology can be used everywhere, starting with large companies in the state.

At the beginning we will have to prove the technology, Jones-Sawyer concedes. We will have to offer it and hope their some companies are willing to take a chance. If we mandate it, it could sabotage us before we get out of the gate. We will have to be sure there is not government overreach with this.

California has some of the strongest legal employee protections in the country. But even with the existing state and federal laws that prohibit discrimination in hiring and firing, Black and Latino workers still face significant discrimination in hiring, according to a 2017 Harvard Business Review report.

The study found that employers called back White applicants 36 percent more times than they did Black applicants with identical resumes. For Latinx applicants, that differential was 24 percent. It also found that the standardized tests some employers use to screen potential employees have been proven to identify qualified candidates, but leads to biased outcomes.

In another study conducted in 2012, researchers switched the names on women resumes to male names. The swap improved ratings from professors who were reviewing the resumes to select candidates for STEM research positions.

This is an amazing, amazing initiative, says Rhonda Gregory, co-founder of the National Diversity Coalition, a non-profit social justice organization that supports the legislation. I think it needs to be sooner than later. Im all for it. For me, this is so compelling. You look at a persons name or gender or area where they are from and people tend to say oh no I dont want to deal with that.

By Tanu Henry | California Black Media

Go here to see the original:
New California Bill Aiming to Eliminate Racial And Other Biases in Hiring - Sacramento Observer

Memorial Neuroscience Institute Performs Its First Robotic Brain Surgery to Help Ease Epileptic Seizures – PR Web

"We are committed in adopting technology that is at the forefront of surgical treatments for epilepsy. The use of the robot will help the Memorial Neuroscience Institute to provide the cutting edge care to our patients.

HOLLYWOOD, Fla. (PRWEB) February 26, 2020

The epilepsy team at Memorial Neuroscience Institute successfully completed its first use of a minimally-invasive, robotic device that helps pinpoint the origin of epileptic seizures on a patient.

The device, now in full use at Memorial Regional Hospital, is called a Robotized Surgical Assistant, or ROSA. With assistance from the robot, neurosurgeons only need to make small, precise incisions in the scalp and skull to place electrodes deep in the brain and investigate where seizures are triggered.

The robot also improves accuracy, safety and can significantly reduce total surgery time, said Tarek Zakaria, MD, Medical Director for the Adult Neurology Program and Epilepsy Program.

By using the new technology, more data will be available to the epilepsy team to offer patients more advanced treatment options and help them to achieve their dreams to be seizure free, Zakaria said.

"We are committed in adopting technology that is at the forefront of surgical treatments for epilepsy," Zakaria said. The use of the robot will help the Memorial Neuroscience Institute to provide the cutting edge care to our patients.

When medication is not enough to control seizures, neurosurgeons like Christopher DeMassi, MD and Daxa Patel, MD may take a surgical approach. That includes altering or removing brain tissue at the location where a patient's seizures begin. However, they can only do so if they can first zero in exactly where that origin is. This is where Rosa can assist.

Recently, they performed the two-part procedure on a 24-year-old female patient, who began having epileptic seizures at age eight and had exhausted all available medications.

The procedure, called robot-assisted stereoelectroencephalography (SEEG), was performed as part of the services offered by the Memorial Neuroscience Institute Comprehensive Epilepsy Center.

Our goal is to always bring in the latest innovative technologies to achieve the best possible outcome for our patients, DeMassi said. This is just the latest advancement available to the South Florida community and keeps us at the front of epilepsy care.

Surgeons used ROSA and a 3-D reconstruction of the patients brain to guide them where to surgically implant electrodes without having to remove sections of her skull. DeMassi and Patel then used the robot's arm to make two- or three-millimeter holes in the scalp through which the electrode wires were passed.

With the electrodes in place, Zakaria and his team were later able to see part of the patient's brain light up on a computer monitor as a seizure began, essentially flagging the point of origin.

Memorial Neuroscience Institute is proud to offer the most technologically advanced and comprehensive services for our patients and the community, said Haroula Protopapadakis Nordem, FACHE, Associate Administrator at Memorial Regional Hospital.

The addition of the ROSA to our program will allow our surgeons to deliver more precise results in a less invasive manner and allow our physicians to treat patients who otherwise might not have had a feasible treatment option, she said.

Memorials epilepsy center is accredited by the National Association of Epilepsy Centers (NAEC) as a Level 4 program, a designation for programs offering the highest level of comprehensive and specialized care.

Memorial Regional Hospital in Hollywood, Fla., is one of the largest hospitals in Florida and is a facility of Memorial Healthcare System, one of the largest healthcare systems in Florida. Its wide scope of medical services and programs includes Memorial Cancer Institute, Breast Cancer Center, Cardiac and Vascular Institute, Neuroscience Center, Comprehensive Weight-Loss Surgery Program, Family Birthplace, Center for Behavioral Health, Sickle Cell Day Hospital, Womens Services, Fitness and Rehabilitation Center, and a level I Trauma Center. For more information, visit memorialregional.com.

Share article on social media or email:

Read this article:
Memorial Neuroscience Institute Performs Its First Robotic Brain Surgery to Help Ease Epileptic Seizures - PR Web

Depletion and repopulation of microglia could be a future therapy for TBI – Drug Target Review

Researchers have shown that by effectively resetting the microglia, recovery of mice after a traumatic brain injury (TBI) was improved.

Depleting microglia and allowing for their repopulation limited brain cell loss as well as cognitive and motor deficits in a murine model of traumatic brain injury (TBI). The researchers suggest their discovery could be used as a novel therapeutic for TBI in humans.

The team, from the University of Maryland School of Medicine (UMSOM), US, targeted overactive microglia in mice with TBIs by administering a CSF-1R inhibitor for one week a month after the initial injury. They chose this point as it is a time at which animals have brain inflammation and neurological deficits.

According to the results of the study, published in Neuroscience, the CSF-1R inhibitor depleted 95 percent of overactive microglia, reducing neurotoxic inflammation. Several weeks later, these cells had regenerated but with characteristics similar to normal microglia, with less inflammatory features.

Use of experimental CSF-1R inhibitor drug reduced inflammation in microglia cells after treatment (right) compared to before treatment (left) (credit: University of Maryland School of Medicine).

The paper states that the CSF-1R inhibitor treated mice recovered better from their TBI than the untreated control group. The population that received the drug had less tissue and neuron loss and significantly better motor and cognitive performance.

We were surprised to see that the extent to which such late treatment could reverse the inflammatory state and the cognitive effects of experimental TBI, said study co-author Dr Rebecca Henry, Research Associate in Anesthesiology at UMSOM. This was a proof-of-concept study that depletion and subsequent repopulation of microglia cells after injury has a strong protective effect, but we clearly need more research to better understand this process before clinical translation.

These pre-clinical studies suggest that the consequences of TBI on brain degeneration and related neurological impairment may be modifiable quite long after injury, said study co-author Dr Alan Faden, the David S. Brown Professor in Trauma at UMSOM. We can potentially alter these effects by even highly delayed targeting of inflammatory pathways, a finding at odds with widely accepted views about treating head injury.

The researchers now intend to explore which genes are driving inflammation and overactivation in microglia following a TBI.

This is an intriguing finding that points to an important role that inflammation plays in chronic debilitation from brain injuries, said UMSOM Dean Dr E Albert Reece, MBA, University Executive Vice President for Medical Affairs and the John Z and Akiko K Bowers Distinguished Professor. Future studies will hopefully lead to new treatments for severe TBI that destroys a patients quality of life.

Read more from the original source:
Depletion and repopulation of microglia could be a future therapy for TBI - Drug Target Review